Emergent BioSolutions (EBS) Short-term Investments (2010 - 2026)

Emergent BioSolutions' Short-term Investments history runs 11 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 67.57% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 67.57% YoY), while the FY2025 annual figure was $3.7 million, down 39.34% from the prior year.
• Short-term Investments was $1.2 million for Q1 2026 at Emergent BioSolutions, down from $3.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $6.5 million in Q3 2024 to a low of $100000.0 in Q3 2022.
• Historically, Short-term Investments has averaged $2.6 million across 4 years, with a median of $2.5 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Short-term Investments soared 640.0% in 2025, then slumped 67.57% in 2026.
• A 4-year view of Short-term Investments shows it stood at $100000.0 in 2022, then soared by 6000.0% to $6.1 million in 2024, then tumbled by 39.34% to $3.7 million in 2025, then plunged by 67.57% to $1.2 million in 2026.
• The last three Short-term Investments figures came in at $1.2 million (Q1 2026), $3.7 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.